Bronchitol (Mannitol) Patent Expiration, LOE Window & CMS Spending

Bronchitol (Mannitol) by Pharmaxis Europe: FDA Orange Book LOE 2027-10-30, 0 AB generics, $250K 2024 CMS Part D & Medicaid spend, and $3,656 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPharmaxis Europe
FDA Application & PathwayN202049 (NDA)
Exclusivity / Cliff HorizonImmediate Cliff (2025-2027)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2027-10-30
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$250K
2024 Medicare Part D Spend$126K
2024 Medicaid Spend$124K
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($3,656 intro WAC)